Community Forum top_calendar.gif top_members.gif top_faq.gif top_search.gif top_home.gif    

Go Back   Community Forum > The Internet Medical Journal > News
User Name
FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Search this Thread Display Modes
Old May 28th, 2005, 06:09
sysadmin sysadmin is offline
Join Date: 2001
Posts: 1,085
Diuretics Work Better than Newer Medicines for High Blood Pressure

[NIH] ALLHAT Study Findings for Racial Groups Show Diuretics Work Better than Newer Medicines for High Blood Pressure.

Diuretics work better than newer therapies in treating high blood pressure and reducing risk of heart disease in both black and non-black patients, according to a long-term, multi-center trial of antihypertensive therapies funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. This analysis by race confirms earlier findings on the effectiveness of diuretics and emphasizes that diuretics should be preferred as a first therapy for most patients with high blood pressure.

Findings of the analysis by race of the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial," or ALLHAT, will appear in the April 6, 2005, issue of The Journal of the American Medical Association. ALLHAT is the first large scale trial—with 33,357 participants—to compare diuretics, calcium channel blockers, and ACE inhibitors as initial therapies in a population with a substantial number of black participants.

The study concludes that diuretics are either similar or superior to newer drugs in lowering blood pressure, in tolerability, and in preventing the major complications from high blood pressure. Across both racial subgroups, there was substantially higher risk of heart failure—37 percent—among participants taking calcium channel blockers compared with those on diuretics. When compared with ACE inhibitors, diuretics were more effective in preventing cardiovascular disease, especially heart failure, for all participants and significantly more effective in reducing high blood pressure and preventing stroke in blacks. Based on this study finding, the authors conclude that as the initial drug for treating high blood pressure, ACE inhibitors work less well than alternatives in black patients.

“This analysis confirms and extends to all races ALLHAT’s original conclusion that diuretics are the right first-line therapy for high blood pressure. While some other recent studies have evaluated newer therapies (including drug combinations), the weight of evidence, particularly in this multi-racial study, supports the diuretic recommendation,” said Dr. Jeffrey Cutler, NHLBI Senior Analyst and study co-author.

High blood pressure affects about 65 million Americans, or one in four adults, and its prevalence increases with age — more than half of those over age 60 have hypertension. High blood pressure is a risk factor for heart disease and the chief risk factor for heart failure and stroke.

The multi-center ALLHAT study is conducted under a contract with the University of Texas Health Science Center at Houston; Dr. Barry Davis is the Principal Investigator and study co-author.

To arrange an interview with Dr. Cutler, contact the NHLBI Communications Office at (301) 496-4236 or email To arrange an interview with study author Jackson Wright, M.D., of Case Western Reserve University, please call George Stamatis, Director, Public Relations, 216-368-3635. To arrange an interview with Dr. Davis, call UT-Houston at 713-500-3030.

Current blood pressure control recommendations are provided in The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, issued by the NHLBI's National High Blood Pressure Education Program in 2003. The report is available online at

NHLBI is part of the National Institutes of Health (NIH), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services. NHLBI press releases and other materials including information about high blood pressure and heart disease, are available online at
Reply With Quote

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
ALLHAT: Quick Reference for Health Care Providers sysadmin News 0 March 9th, 2003 15:35
2003.01.01 sysadmin News 0 February 15th, 2003 12:10
in diabetic nephropathy, what is the target systolic blood pressure? sysadmin Chronic Renal Disease 0 August 31st, 2002 11:01

All times are GMT -8. The time now is 02:37.

Powered by: vBulletin Version 3.0.3
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.

Be careful about reading health books. You may die of a misprint.  
- Mark Twain (1835 - 1910)

We are committed to your good health. That means that while we provide editorial medical information, we must insist that you work with your own doctor in regards to your personal health issues. All content on Medjournal.Com is strictly editorial. It constitutes medical opinion, NOT ADVICE. We do not endorse or recommend the content of or the sites that are linked FROM or TO Use common sense by consulting with your doctor before making any lifestyle changes or other medical decisions based on the content of these web pages. Medjournal.Com and the Internet Medical Journal shall not be held liable for any errors in content, advertising, or for any actions taken in reliance thereon.